Trump threatens up to 100% tariffs on brand-name drugs


Full story

President Donald Trump celebrated the anniversary of his 2025 “Liberation Day” tariffs on Thursday by issuing a new executive order imposing more tariffs. This one targets pharmaceutical drugs.

Under the new order, brand-name drugs from companies that don’t cut deals with the Trump administration in the coming months could face tariffs of up to 100%.

QR code for SAN app download

Download the SAN app today to stay up-to-date with Unbiased. Straight Facts™.

Point phone camera here

Companies that sign on to the president’s “most favored nation” pricing plan and build facilities in the U.S. would face no tariffs. Companies that build in the U.S. but don’t join the pricing plan would start at 20%, with tariffs rising to 100% over four years.

Larger drugmakers would have 120 days to negotiate before tariffs take effect, while smaller companies would get 180 days.

Who will the order impact?

It is not yet clear which companies or drugs would be hit by the tariffs.

So far, the administration says it has reached deals with 17 major drugmakers, including 13 that are finalized.

Through previous trade agreements, some nations will already see lower tariff rates.The European Union, Japan, South Korea and Switzerland are set to only face 15% tariffs on pharmaceuticals, while the U.K.’s will be 10%.

And those European companies have the ability to lower their tariffs to 0% if they build manufacturing plants in the U.S.

Trump’s reasoning for the order

Trump wrote in his order that he deemed the tariffs necessary “to address the threatened impairment of the national security posed by imports of pharmaceuticals and pharmaceutical ingredients.”

The tariffs on pharmaceutical drugs are being imposed under Section 232 of the Trade Expansion Act of 1962. That gives the president the power to levy tariffs over concerns about national security risks.

Even though the new tariffs were announced on “Liberation Day,” they’re not related to the sweeping global tariffs Trump imposed last year, which have been struck down by the Supreme Court. They’re also separate from the 10% global tariff that Trump imposed to replace the tariffs the Supreme Court blocked.

Tags: , , , , , , , ,

SAN provides
Unbiased. Straight Facts.

Don’t just take our word for it.


Certified balanced reporting

According to media bias experts at AllSides

AllSides Certified Balanced May 2025

Transparent and credible

Awarded a perfect reliability rating from NewsGuard

100/100

Welcome back to trustworthy journalism.

Find out more

Why this story matters

A new executive order imposes tariffs on imported pharmaceutical drugs, with rates that vary by company and country and timelines already set for negotiations.

Drug prices may rise

Brand-name drugs from companies that don't reach deals with the administration could face tariffs up to 100%, according to the order, though which specific drugs are affected is not yet clear.

Negotiation windows are fixed

Larger drugmakers have 120 days and smaller companies 180 days to negotiate before tariffs take effect, setting a defined timeline for potential market changes.

Country of origin affects rates

Drugs from the EU, Japan, South Korea and Switzerland face a stated 15% tariff rate, while UK-sourced drugs face 10%, creating different cost structures depending on where a drug is manufactured.

SAN provides
Unbiased. Straight Facts.

Don’t just take our word for it.


Certified balanced reporting

According to media bias experts at AllSides

AllSides Certified Balanced May 2025

Transparent and credible

Awarded a perfect reliability rating from NewsGuard

100/100

Welcome back to trustworthy journalism.

Find out more

Daily Newsletter

Start your day with fact-based news

Start your day with fact-based news

Learn more about our emails. Unsubscribe anytime.